TriSalus Life Sciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2021 | $23.7M | $251.8M | $1.1M |
| Jun 2021 | $22.7M | $251.2M | $642.9K |
| Sep 2021 | $20.4M | $250.8M | $277.8K |
| Dec 2021 | $17.3M | $250.5M | $200.9K |
| Mar 2022 | $14.3M | $250.4M | $50.9K |
| Jun 2022 | $12.0M | $250.6M | $69.2K |
| Sep 2022 | $12.2M | $251.3M | $207.6K |
| Dec 2022 | $34.3M | $22.0M | $9.4M |
| Mar 2023 | $14.2M | $20.5M | $136.8K |
| Jun 2023 | $15.3M | $12.2M | $104.0K |
| Sep 2023 | $25.1M | $33.6M | $21.4M |
| Dec 2023 | $51.7M | $24.6M | $11.8M |
| Mar 2024 | $52.8M | $17.9M | $4.0M |
| Jun 2024 | $56.6M | $32.4M | $16.5M |
| Sep 2024 | $47.9M | $27.5M | $11.3M |
| Dec 2024 | $49.9M | $24.0M | $8.5M |
| Mar 2025 | $63.0M | $28.6M | $13.0M |
| Jun 2025 | $60.7M | $41.3M | $26.5M |
| Sep 2025 | $63.2M | $36.5M | $22.7M |
| Dec 2025 | $69.2M | $35.3M | $20.4M |
| Mar 2026 | $58.2M | $71.0M | $56.6M |
| Jun 2026 | $55.9M | $62.4M | $46.3M |